Patents Assigned to Dynal AS
  • Publication number: 20080039578
    Abstract: A process for the preparation of amine-functionalised vinyl polymer particles which process comprises suspension polymerizing minostyrene together with at least one other vinylic monomer and optionally a crosslinking agent.
    Type: Application
    Filed: August 21, 2007
    Publication date: February 14, 2008
    Applicant: INVITROGEN DYNAL AS
    Inventors: Geir Fonnum, Ellen Weng, Elin Aksnes, Rolf Nordal, Preben Mork, Svein Togersen, Julian Cockbain
  • Publication number: 20070190559
    Abstract: The present invention provides a method of isolating nucleic acid from a sample, said method comprising contacting said sample with a detergent and a solid support, whereby soluble nucleic acid in said sample is bound to the support, and separating said support with bound nucleic acid from the sample. Where the method of the invention is used to isolate DNA, it may conveniently be couple with a further step to isolate RNA from the same sample.
    Type: Application
    Filed: February 5, 2007
    Publication date: August 16, 2007
    Applicant: INVITROGEN DYNAL AS
    Inventors: Arne Deggerdal, Frank Larsen
  • Patent number: 7173124
    Abstract: The present invention provides a method of isolating nucleic acid from a sample, said method comprising contacting said sample with a detergent and a solid support, whereby soluble nucleic acid in said sample is bound to the support, and separating said support with bound nucleic acid from the sample. Where the method of the invention is used to isolate DNA, it may conveniently be couple with a further step to isolate RNA from the same sample.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: February 6, 2007
    Assignee: Invitrogen Dynal AS
    Inventors: Arne Helge Deggerdal, Frank Larsen
  • Patent number: 6610479
    Abstract: Enzymes or catalytic fragments thereof reversibly inactivated by attachment to an immobilizing moiety which may comprise a magnetic particle are activated by release from the immobilizing moiety. The enzyme or fragment may be in the form of a fusion protein that is attached to the immobilizing moiety via a pair of affinity binding partners such that the enzyme or fragment is reversibly inactivated, and release of the fusion protein from the immobilizing moiety activates the enzyme or fragment. Enzymes include DNA polymerases, DNA ligases, Reverse transcriptases and RNA polymerases. The enzyme or fragment may be thermostable, and the fusion protein can be bound to the immobilizing moiety via a heat-labile linkage. Activation of the reversibly inactivated immobilized enzyme or fragment has particular utility in PCR and analogous nucleic acid amplification techniques.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: August 26, 2003
    Assignee: Dynal AS
    Inventors: Joakim Lundeberg, Mathias Uhlén
  • Patent number: 6482592
    Abstract: The invention provides a method of improving the binding of a series of consecutive nucleotide bases to a complementary target nucleic acid molecule in a sample, wherein said method comprises at least the step or steps of binding a complementary modular oligonucleotide of at least two parts (modules) including said nucleotide bases to adjacent stretches of said target nucleic acid molecule in said sample, especially methods of detection/isolation, particularly in the isolation of primer extension products and methods in which the modular oligonucleotide is a primer, modular oligonucleotides themselves and their use in methods of the invention.
    Type: Grant
    Filed: September 15, 1998
    Date of Patent: November 19, 2002
    Assignee: Dynal AS
    Inventors: Joakim Lundeberg, Mathias Uhlen
  • Patent number: 5759820
    Abstract: The process includes the steps of: a) contacting a liquid containing mRNA with an insoluble support having DNA probes attached thereto via the 5' -terminus thereof whereby the MRNA is hybridized to said probes and hence to said support; b) removing said liquid; and c) adding enzymes and nucleotides in solution whereby the probe functions as a primer to produce single stranded cDNA on the mRNA probe. The probe DNA may be oligo-dT or a specific DNA sequence, such as one that is complementary to a conserved region in a class of mRNA molecules. The insoluble support comprises magnetic particles which are monodisperse polymer particles comprising superparamagnetic iron oxide, a coating to reduce non-specific binding and a substituent for attaching an oligonucleotide.
    Type: Grant
    Filed: July 25, 1994
    Date of Patent: June 2, 1998
    Assignee: Dynal AS
    Inventors: Erik Hornes, Lars Korsnes
  • Patent number: 5512439
    Abstract: Monodisperse, superparamagnetic particles carrying a plurality of molecules of an oligonucleotide are disclosed and may be used inter alia for sequencing single-stranded nucleic acids. The oligonucleotide may be covalently attached or affinity bonded to the particles either by their 3' or 5' termini. The particles have a specific gravity in the range 1.1-1.8 and are 1-10 microns in diameter. A kit for the isolation or processing of target nucleic acid is also disclosed.
    Type: Grant
    Filed: July 6, 1994
    Date of Patent: April 30, 1996
    Assignee: Dynal AS
    Inventors: Erik Hornes, Lars Korsnes
  • Patent number: 5429927
    Abstract: The present invention provides a method of cleaving an antigen/anti-antigen or hapten/anti-hapten linkage joining two particles comprising reacting said linkage with a secondary antibody, or fragment thereof, binding to said anti-antigen or anti-hapten, and a kit for performing such a method. The method of the invention has particular utility in the separation of cells.
    Type: Grant
    Filed: November 10, 1992
    Date of Patent: July 4, 1995
    Assignee: Dynal AS
    Inventors: John Afseth, Steiner Funderud, Laurent Caignault, Mohamad Mortada
  • Patent number: 5348876
    Abstract: The present invention provides modified IgG3 containing human constant regions which has a shorter total-hinge region compared with normal human IgG3. Also described is a method for assaying an antibody against a specific antigen or hapten for its effectiveness in complement activation in an animal species, wherein the antibody is contacted with the immobilized antigen or hapten to form an immobilized antibody/antigen or hapten complex which is then contacted with complement from the relevant animal species, followed by assay of components of the complement complex thereby formed; whereby the extent and nature of complement activation by the antibody in the sample may be determined.
    Type: Grant
    Filed: March 12, 1992
    Date of Patent: September 20, 1994
    Assignee: Dynal AS
    Inventors: Terje Michaelsen, Inger Sandlie